Depression: disease or symptom?

Globally, more than 50% of all people are infected [8], with the prevalence of escalating with age. [9]

Helicobacter Pylori is a gram-negative bacterium that colonises within the human gastrointestinal tract (this includes the mouth).

Symptoms:

• Belching
• Nausea
• Vomiting
• Difficulty swallowing
• Abdominal discomfort
• Upper abdominal bloating
• Decreased appetite
• Peptic ulcers
• Bad breath
• Heartburn
• Reoccurring oral plaque
• Gingivitis
• Tooth cavities

‍

Risks:

• H. Pylori infection is the main cause of chronic gastritis, with an infection rate between 80%-95% in sufferers. [7]
• It is present in almost all cases of duodenal ulcers and most cases of gastric ulcer [10] with as many as 90% of individuals with ulcers being infected.
• H. Pylori is a significant contributing factor for the risk of gastric cancers.
• H. Pylori burrows deep within parietal cells (cells that secrete stomach acid), not only does this make it harder to eradicate, but this also leads to unique symptoms within the host. One factor being hypochlorhydria (low levels of stomach acid secreted within the body); this prevents the host from sterilising bacteria in food, reduces the ability to obtain nutrients desired from food and the inability to assimilate certain key minerals, such as zinc or iron.
• Reduced intrinsic factor (IF) production is also likely for individuals suffering from a H. Pylori infection. IF is essential to bind with vitamin B12, preventing further breakdown from stomach acid along with attaching to the surface of the ileum to allow for absorption of B12 into the body.
• H. Pylori can also block vitamin C absorption, thus compounding to the amount of oxidative damage inflicted onto the body.
• H. Pylori infection augments the gastric mucosal damage induced by NSAIDs.
• H. Pylori antagonises Aspirin-induced delayed ulcer healing due to suppression of acid secretion by the enhancement of PGE2 possibly derived by COX2 expression.
• Benefits:
  Due to the nature of the parasite being a gram-negative bacteria, it shifts the immune system more towards a Th1 mediated response as opposed to Th2 – this can reduce the severity of allergies, asthma and other humeral/mucosal reactions.

‍

Benefits:

Due to the nature of the parasite being a gram-negative bacteria, it shifts the immune system more towards a Th1 mediated response as opposed to Th2 – this can reduce the severity of allergies, asthma and other humeral/mucosal reactions.

‍

References:

1. Morales-Espinosa R, et al., Oral Microbiol Immunol. 2009
2. Nguyen AM, et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995
3. Miyabayashi H, et al., Helicobacter. 2000
4. Gebara EC, et al., J Clin Periodontol. 2006
5. Dye BA, et al., Am J Public Health. 2002
6. Eskandari A, et al. Med Oral Patol Oral Cir Bucal.
7. Abro AH, et al. J Ayub Med Coll Abbottabad. 2011
8. Saudi J Gastroenterol. 2014
9. J Gastrointestin Liver Dis. 2011
10. J Gastroenterol Hepatol. 2011
11. Surveillance of Helicobacter pylori antibiotic resistance in England and Wales; Public Health England, 2008
12. Jernberg, C, et al. 2010

Are you currently exposed to phthalates on a regular basis? Were you exposed during early developmental stages—for example, through maternal exposure such as a mother working in a hair salon while pregnant? Have you noticed symptom improvement after reducing phthalate exposure?

Higher phthalate levels have been associated with a two-fold increase in the rate of endometriosis. Phthalates are present in almost anything fragranced and are widely used in soft plastics, vinyl, cleaning products, nail polish, and perfumes. As early as 2002, environmental groups reported that over 70% of personal care products contained phthalates. Today, according to the Environmental Protection Agency, more than 470 million pounds of phthalates are produced each year.

Phthalates are now officially recognised as reproductive toxins throughout both the European Union and the United States. Animal studies show that rats given high doses of certain phthalates stopped ovulating altogether. Phthalates reduce oestrogen production by ovarian follicles—oestrogen being one of the primary drivers of follicle growth and egg development in both animals and humans. Suppression of oestrogen by follicle cells would be expected to impair follicle growth, helping explain why women with endometriosis often exhibit significantly higher phthalate levels than those without the condition.

Potential sources of exposure are extensive. Plastics can leach into food, particularly when food is packaged while hot or stored in plastic for long periods. Personal care products are a major contributor, including cosmetics, hair products, lotions, infant care products, medications, medical devices, nail polish, and perfumes.

Vinyl products are another source, such as shower curtains, flooring, wallpapers, blinds, diaper mats, rain gear, inflatable mattresses, school supplies, car interiors, and yoga mats. Additional exposures may come from air fresheners, electronics, plastic jewellery, sex toys, and children’s toys.

Given their prevalence and biological impact, understanding and minimising phthalate exposure is an important consideration in hormone and reproductive health.

Endometriosis is costing women, and Australia, an estimated total of $9.7 billion per year in medical bills and lost productivity, according to new research.
This equates to an average cost of $30,000 per sufferer per year, both personally and to society.

Around 20–40% of this cost sits directly within the health sector:
– Medications
– Doctor visits
– Assisted reproductive technology (e.g. IVF)
– Transport costs to attend appointments

The remaining 60–80% is due to lost productivity, either from absenteeism or presenteeism—being physically present but unable to perform due to severe pain and discomfort.

Reducing pain caused by endometriosis by just 20% could save Australia billions.

This condition affects more than 830,000 women—over 10% of Australia’s female population.

Symptoms vary widely, contributing to the condition being overlooked or misdiagnosed for 7–12 years, with 1 in 5 doctors missing the diagnosis.
At least 50% of patients experience fertility issues.

Given the scale, one would expect significantly more research, education, awareness, investment, and progress in this field.

Yet many men remain unaware of what endometriosis even is.

This is not necessarily the fault of men.
It is a failure of the system to provide adequate education and visibility.

Women are not being treated with the care, respect, or urgency this condition demands.

It’s time things changed.